Multiple safety failures identified in chemical explosion

By Jim Morris

A new report on a 2008 explosion at a West Virginia pesticide factory offers a chilling account that raises questions about safeguards at th

25 years after Bhopal, U.S. plant still using same toxic chemical

By M.B. Pell and Jim Morris

Earlier this week, seven former executives of Union Carbide India Ltd. were convicted of “death by negligence” and sentenced to two-year jai

Chemical that killed thousands in Bhopal finally abandoned by U.S. producer

By iWatch News

Sooner than expected, the last major U.S. producer of the chemical that killed thousands in Bhopal, India, 26 years ago –and was nearly rele
Advertisement

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C
Advertisement

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Deep pockets contribute to success

By M. Asif Ismail

Industry spends millions on state campaign donations, Calif. fight

Excerpts from this story referencing "Pharmaceutical companies":

"… ick Perry of Texas and Mark Earley, the party's 2001 candidate in Virginia.Pharmaceutical companies also spent significant amounts themselves on campaign donations to state c …"

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Pages